News On Projects
Products & Services
Projects Database
Tenders Database
E - Newsletter
EPXonline.com
Project Financing
Contracts & Awards
Energy
Electricity
Mining
Oil & Gas
Infrastructure
Airport
Port
Railway
Road
Freezone
Construction
Manufacturing
Cement
Engineering
Automobile
Plastic
Metal
Textile
Paper & Packaging
Leather
Sugar
Edible Oil
Electrical & Electro
Processing
Chemical
Drugs & Pharma
Fertiliser
I-C-T
Communication
IT
Telecom
Water
Pump Station
Water Treatment
Water Supply
Hospitality
Hotel
Restaurant
Resort
Entertainment
Sports
Multiplex
Theme Park
Food & Beverages
Hospital
Service
Social
Science
Irrigation
Government
Policy
Economic Indicators
Company News
Commerce
Miscellaneous
News Uploaded On : Thursday, October 28, 2010 11:56:00 AM IND Back  |  Latest Projects  |  Latest Tenders
 
 E-mail this to a friend        Printable version       Story Viewed 3118 Times
Biocon plans a unit in Malaysia
Bangalore: Biocon plans to invest $161 million (Rs 725 crore) in Malaysia by 2014 to establish a biomanufacturing and research and development unit to manufacture high-end biosimilars and biopharmaceuticals.

The company today signed an agreement with Malaysian Biotechnology Corporation, an agency for the biotechnology industry in Malaysia, for the project. The unit will be set up in Bio-Xcell , a biotechnology park and ecosystem in Iskander Malaysia, Johor.

The total investment of $161 million will be part-funded from the proceeds of the Pfizer marketing deal, along with internal accruals.

According to the agreement, Biocon will receive $200 million (about Rs 900 crore) upfront and additional development and regulatory milestone payments of up to $150 million (about Rs 675 crore) from Pfizer.

The new Malaysian facility would manufacture biosimilars, including those four insulin analogues for which marketing deal had been signed with Pfizer.

The $161 million was part of its first-phase investment plan and it would invest more after 2014.

Post your comments:

Your name: *
E-Mail Id:
E-mail ID will not be published
Comment: *
Maximum 500 Characters
    
Related Stories
Shandong Chambroad commissions first propylene and isobutylene coproduction plant in China.
Glenmark to set up new injectable plant in US.
Dishman looking to sell China plant to pare off debt.
Dabur Indian to invest Rs.100 Crore in Africa
RELATED PROJECTS & TENDERS
ADVERTISEMENT
MOST POPULAR STORIES NOW
For all enquiries please contact
Tel: 022 - 25961254, 25960909
Mobile: 9821464666/09751178830
Mail: marketing@newsonprojects.com

OUR OTHER PRODUCTS & SERVICES:    Projects Database   |   Project e-Newsletter   |   Tenders Database   |   Commissioned Power Plants   |   Company Index
About Us   |   Contact Us   |   Terms of Use   |   Advertise with Us   |   Privacy Policy   |   Disclaimer   |   Feedback